Back to Research Hub
Bristol-Myers Squibb Company
BMY
$56.48+0.91 (+1.64%)
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases.
StreetsValue research for Bristol-Myers Squibb Company (BMY)
Members get the full report for Bristol-Myers Squibb Company: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.